Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Bluebird bio

Request full access

Integrated product platforms encompass gene therapy, cancer immunotherapy and gene editing

Cambridge, United StatesFounded 1993Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2013

Bluebird bio in the Cambridge ecosystem

Live from Dealroom

The Bluebird bio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later12 investors entered at this stage

Employees mapped 308 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 8 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$100M

43 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Bluebird bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.